Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

N/A

2(40.0%)

Phase 4

1(20.0%)

5Total

Phase 2(2)

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02312557Phase 2Active Not Recruiting

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Role: collaborator

NCT05292001Phase 4Recruiting

Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma

Role: collaborator

NCT04468932Not ApplicableRecruiting

Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

Role: collaborator

NCT06409169Not ApplicableRecruiting

DBS TaT in Peer-assisted Telemedicine for Hepatitis C

Role: collaborator

NCT03942549Unknown

Changes in the Bladder Micro-environment Following Midurethral Sling Surgery for Stress Urinary Incontinence

Role: collaborator

NCT00962429Phase 2Completed

Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy

Role: collaborator

All 6 trials loaded